$92.50
11.02% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US5898891040
Symbol
MMSI

Merit Medical Systems, Inc. Stock price

$92.50
-9.39 9.22% 1M
-3.13 3.27% 6M
-4.22 4.36% YTD
+20.56 28.58% 1Y
+28.02 43.46% 3Y
+59.01 176.20% 5Y
+73.30 381.77% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-11.46 11.02%
ISIN
US5898891040
Symbol
MMSI
Sector

Key metrics

Market capitalization $5.44b
Enterprise Value $5.86b
P/E (TTM) P/E ratio 45.58
EV/FCF (TTM) EV/FCF 31.55
EV/Sales (TTM) EV/Sales 4.33
P/S ratio (TTM) P/S ratio 4.02
P/B ratio (TTM) P/B ratio 3.94
Revenue growth (TTM) Revenue growth 8.07%
Revenue (TTM) Revenue $1.35b
EBIT (operating result TTM) EBIT $163.77m
Free Cash Flow (TTM) Free Cash Flow $185.66m
Cash position $378.82m
EPS (TTM) EPS $2.03
P/E forward 35.95
P/S forward 3.68
EV/Sales forward 3.96
Short interest 8.01%
Show more

Is Merit Medical Systems, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Merit Medical Systems, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Merit Medical Systems, Inc. forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Merit Medical Systems, Inc. forecast:

Buy
92%
Hold
8%

Financial data from Merit Medical Systems, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,354 1,354
8% 8%
100%
- Direct Costs 713 713
2% 2%
53%
641 641
22% 22%
47%
- Selling and Administrative Expenses 275 275
27% 27%
20%
- Research and Development Expense 87 87
6% 6%
6%
279 279
24% 24%
21%
- Depreciation and Amortization 115 115
13% 13%
8%
EBIT (Operating Income) EBIT 164 164
33% 33%
12%
Net Profit 120 120
27% 27%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Merit Medical Systems, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merit Medical Systems, Inc. Stock News

Neutral
GlobeNewsWire
9 days ago
Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms.
Neutral
GlobeNewsWire
11 days ago
SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomized arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial are scheduled for publication in the April issue of Kidney International . Twelve-month results from the randomized arm of the WAV...
Neutral
GlobeNewsWire
18 days ago
SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M. (EDT) and the bell ringing takes place at 9:30 ...
More Merit Medical Systems, Inc. News

Company Profile

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Head office United States
CEO Fred Lampropoulos
Employees 7,400
Founded 1987
Website www.merit.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today